Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Assessment of PD-1 positive cells on initial and secondary resected tumor specimens of newly diagnosed glioblastoma and its implications on patient outcome.

Journal of neuro-oncology - 1 Jun 2017

Miyazaki Tsubasa, Ishikawa Eiichi, Matsuda Masahide, Akutsu Hiroyoshi, Osuka Satoru, Sakamoto Noriaki, Takano Shingo, Yamamoto Tetsuya, Tsuboi Koji, Matsumura Akira

Abstract excerpt

Glioblastoma (GBM) is the most common type of malignant brain tumor and has a very poor prognosis. Most patients relapse within 12 months despite aggressive treatment and patient outcome after recurrent is extremely worse. This study was designed to clarify the change of the molecular expression, including programmed cell death 1 (PD-1) and PD-ligand 1 (PD-L1), on the initial and secondary resected tumor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B7-H1 Antigen
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD8 Antigens

Share to Glioblastoma

Share to Isocitrate Dehydrogenase

Share to Ki-67 Antigen

Share to Programmed Cell Death 1 Receptor

Share to Statistics, Nonparametric

Source

Identifiers

PMID: 28447277
DOI: 10.1007/s11060-017-2451-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Assessment of PD-1 positive cells on initial and secondary resected tumor specimens of newly diagnosed glioblastoma and its implications on patient outcome.PMID 28447277Read ↗

Molecular characteristics of single patient-derived glioma stem-like cells from primary and recurrent glioblastoma.Semantic proximity Read ↗

Neoadjuvant Triplet Immune Checkpoint Blockade in Newly Diagnosed GlioblastomaSemantic proximity Read ↗

Primary and secondary gliosarcomas: clinical, molecular and survival characteristics.Semantic proximity Read ↗

The Change of Soluble Programmed Cell Death-Ligand 1 in Glioma Patients Receiving Radiotherapy and Its Impact on Clinical Outcomes.Semantic proximity Read ↗

Impact of platinum-based chemotherapy on the tumor mutational burden and immune microenvironment in non-small cell lung cancer with postoperative recurrence.Semantic proximity Read ↗

Expression of programmed cell death-ligand 1 and its correlation with clinical outcomes in gliomasSemantic proximity Read ↗

The Change of Soluble Programmed Cell Death-Ligand 1 (sPD-L1) in Glioma Patients Receiving Radiotherapy and Its Impact on Clinical OutcomeSemantic proximity Read ↗

Analysis of immunobiologic markers in primary and recurrent glioblastoma.Semantic proximity Read ↗

Correlation between lower balance of Th2 helper T-cells and expression of PD-L1/PD-1 axis genes enables prognostic prediction in patients with glioblastomaSemantic proximity Read ↗

Comprehensive analysis of PD-L1 expression in glioblastoma multiforme.Semantic proximity Read ↗

Clinical and genomic features in patients with second primary glioblastoma following first primary renal cell carcinoma.Semantic proximity Read ↗

The potentiality of immunotherapy for sarcomas: a summary of potential predictive biomarkers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.